PMID- 19482867 OWN - NLM STAT- MEDLINE DCOM- 20090821 LR - 20111117 IS - 1352-4585 (Print) IS - 1352-4585 (Linking) VI - 15 IP - 6 DP - 2009 Jun TI - Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis. PG - 771-4 LID - 10.1177/1352458509104588 [doi] AB - BACKGROUND: Multiple sclerosis (MS) is associated with human leukocyte antigen (HLA) HLA-DRB1*15. Recent evidence that CD8 T cells are implicated in MS suggests that HLA class I may also contribute. An association of HLA-A*02 and A*03 alleles has been described. OBJECTIVES: We examined the influence of HLA-A*02 and HLA-A*03 in Portuguese patients with MS, independently of HLA-DRB1*15 using a logistic regression model. CONCLUSIONS: DRB1*15 increased the risk of developing MS and HLA-A*02 decreased the risk. A*03 had no effect. To analyze if HLA-A*02 association was independent from DRB1*15, an interaction between these two alleles was introduced in the model; no significant interaction was found. FAU - Silva, A M AU - Silva AM AD - Departamento de Neurologia, Centro Hospitalar do Porto-Hospital de Santo Antonio, Porto, Portugal. anadmsilva@yahoo.com FAU - Bettencourt, A AU - Bettencourt A FAU - Pereira, C AU - Pereira C FAU - Santos, E AU - Santos E FAU - Carvalho, C AU - Carvalho C FAU - Mendonca, D AU - Mendonca D FAU - Costa, P P AU - Costa PP FAU - Monteiro, L AU - Monteiro L FAU - Martins, B AU - Martins B LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Mult Scler JT - Multiple sclerosis (Houndmills, Basingstoke, England) JID - 9509185 RN - 0 (HLA-A Antigens) RN - 0 (HLA-A*02 antigen) RN - 0 (HLA-A2 Antigen) RN - 0 (HLA-DR Antigens) RN - 0 (HLA-DRB1 Chains) RN - 0 (HLA-DRB1*15 antigen) SB - IM MH - CD8-Positive T-Lymphocytes/immunology MH - Genetic Predisposition to Disease/epidemiology MH - HLA-A Antigens/*genetics MH - HLA-A2 Antigen MH - HLA-DR Antigens/genetics MH - HLA-DRB1 Chains MH - Humans MH - Logistic Models MH - Multiple Sclerosis/*epidemiology/*genetics/immunology MH - Phenotype MH - Portugal/epidemiology MH - Risk Factors EDAT- 2009/06/02 09:00 MHDA- 2009/08/22 09:00 CRDT- 2009/06/02 09:00 PHST- 2009/06/02 09:00 [entrez] PHST- 2009/06/02 09:00 [pubmed] PHST- 2009/08/22 09:00 [medline] AID - 15/6/771 [pii] AID - 10.1177/1352458509104588 [doi] PST - ppublish SO - Mult Scler. 2009 Jun;15(6):771-4. doi: 10.1177/1352458509104588.